Rutgers neuroscientist Peng Jiang was visiting his hometown of Qianshan, a metropolis successful China's Anhui province, erstwhile a neighbour came to his parents' location pinch a communicative that would enactment pinch him.
The man's mother had been diagnosed pinch Alzheimer's illness successful her early 60s. After astir a decade of decline, she nary longer recognized her ain son. One morning, she looked astatine him and asked gently, "How is your mother doing? Is she well?"
As nan neighbour recounted nan moment, he collapsed into tears. He told Jiang that Alzheimer's runs successful his family and that he fears his ain children whitethorn 1 time watch him slice nan measurement he watched his mother's representation vanish.
That conversation, which took spot respective years ago, became a turning constituent for Jiang, an subordinate professor successful nan Department of Cell Biology and Neuroscience astatine nan School of Arts and Sciences. Already heavy into Alzheimer's research, Jiang returned to his laboratory pinch renewed urgency.
"The truth that location is still nary effective curen fuels my determination to prosecute caller therapeutic ideas," said Jiang, besides a module personnel of nan Rutgers Brain Health Institute.
Now, Jiang and his neuroscience workfellow Mengmeng Jin, nan first writer of nan study, person made a find they said could reshape really scientists deliberation astir Alzheimer's treatment. Their study, published successful Nature Neuroscience, identifies a uncommon cistron mutation that appears to protect nan brain's immune cells from nan harm typically caused by nan disease.
We judge it's a awesome beforehand successful nan field. Rather than looking astatine mutations that summation risk, we're searching for mutations that tin confer resilience."
Peng Jiang, Rutgers neuroscientist
The activity reflects a displacement successful Alzheimer's illness research, Jiang said. Instead of focusing only connected removing toxic proteins, scientists whitethorn beryllium capable to fortify nan brain's ain defense strategy to support it resilient and patient longer.
For Jiang, nan subject is inseparable from nan quality impact.
"We're trying to study from quality to harness a people occurring mutation for therapeutic purposes," he said.
Individuals pinch Down syndrome, who transportation 3 copies of chromosome 21, almost universally create early-onset Alzheimer's illness owed to nan accelerated accumulation of toxic proteins successful nan brain. Yet a mini subset of group pinch Down syndrome shows singular resilience – they ne'er create dementia contempt having nan aforesaid pathological buildup.
This study motivated nan Rutgers squad to analyse nan biologic effects of a uncommon mutation, CSF2RB A455D, identified successful nan immune cells of a mini number of individuals pinch Down syndrome. Their investigation reveals antecedently chartless functions of this mutation and provides caller insights into mechanisms that whitethorn power nan consequence of neurodegeneration.
They focused connected microglia, nan brain's immune cells that enactment arsenic housekeepers, clearing distant discarded and protecting neurons. Using stem compartment technology, nan researchers created quality microglia pinch nan mutation and placed them into nan brains of mice to create a chimeric rodent encephalon model, allowing them to observe really these quality cells usability successful a surviving encephalon environment. These mice were past exposed to Alzheimer's-related proteins.
The results amazed researchers. The microglia pinch nan mutation stayed young and avoided semipermanent inflammation that usually damages encephalon cells. The cells were amended astatine cleaning up harmful proteins and protecting adjacent neurons.
When researchers placed some mutated and unmutated microglia together successful encephalon environments containing Alzheimer's-related proteins, nan mutated microglia slow took over. The unmutated microglia became weaker complete time, while nan mutated ones stayed strong, efficaciously refreshing nan brain's immune system. This effect showed up not only successful cells from group pinch Down syndrome but successful cells from nan wide population.
"We transplant nan cells, past inject pathological proteins," said Jin, a postdoctoral investigation fellow. "We observe really nan quality microglia react."
The find opens nan doorway to caller therapeutic strategies, nan scientists said. One attack involves transplanting microglia engineered pinch nan protective mutation into patients' brains. Another could impact utilizing gene therapy to present nan mutation straight into existing microglia, perchance restoring their expertise to take sides against Alzheimer's damage.
Other Rutgers scientists who contributed to nan study included: Ziyuan Ma, a doctoral student; Rui Dang, a postdoctoral associate; Haiwei Zhang, a erstwhile postdoctoral associate; Rachael Kim, a erstwhile undergraduate researcher; and Ava Papetti, a postgraduate fellow, each successful nan Department of Cell Biology and Neuroscience. Scientists astatine nan University of California, Irvine, Gladstone Institutes, Florida International University, and Nanjing Medical University successful China besides contributed to nan study.
Source:
Journal reference:
Jin, M., et al. (2025). A myeloid trisomy 21-associated cistron version is protective from Alzheimer’s disease. Nature Neuroscience. doi: 10.1038/s41593-025-02117-8. https://www.nature.com/articles/s41593-025-02117-8
English (US) ·
Indonesian (ID) ·